Defence Therapeutics (XCNQ:DTC) Total Payout Ratio : 0.44 (As of May. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Defence Therapeutics Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Defence Therapeutics's current Total Payout Ratio is 0.44.

Defence Therapeutics Total Payout Ratio Historical Data

The historical data trend for Defence Therapeutics's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Defence Therapeutics Total Payout Ratio Chart

Defence Therapeutics Annual Data

Trend

Jun20

Jun21

Jun22

Total Payout Ratio

3.38

0.97

0.15

Defence Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Total Payout Ratio	Get a 7-Day Free Trial										0.71	0.05	3.54	-	0.05

Competitive Comparison of Defence Therapeutics's Total Payout Ratio

For the Biotechnology subindustry, Defence Therapeutics's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Defence Therapeutics's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Defence Therapeutics's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Defence Therapeutics's Total Payout Ratio falls into.

Defence Therapeutics Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Defence Therapeutics's Total Payout Ratio for the fiscal year that ended in Jun. 2022 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	1.098	+	0)	/	-7.344
	=	0.15

Defence Therapeutics's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0.424	+	0)	/	-8.32
	=	0.05

Defence Therapeutics Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Defence Therapeutics's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Defence Therapeutics (XCNQ:DTC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Defence Therapeutics Inc (XCNQ:DTC) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

DTCFF:USA DTC:Germany

Address

200 Burrard Street, Suite 1680, Vancouver, BC, CAN, V6C3L6

Website

https://www.defencetherapeutics.com

Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The Company has one operating segment, being research and development.

Executives

Sarkis Meterissian

Director